# Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

> **NCT07634640** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Florida** · enrollment: 70 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction (HFPEF)

## Interventions

- **DRUG:** Ferumoxytol infusion

## Key facts

- **NCT ID:** NCT07634640
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-03
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634640, "Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07634640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*